Skip to main content

Table 3 Survival time

From: Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study

1-year survival rate 3-year survival rate 5-year survival rate mOS mOS after metastasis
N % N % N %
17 62.96 6 22.22 4 14.81 22.0 (95% CI 10.789–33.211) 23.0 (95% CI 16.443–29.557)